## **Core Concept**
Goodpasture syndrome is a rare autoimmune disorder characterized by the presence of autoantibodies against the basement membrane of the lungs and kidneys. This condition leads to the formation of anti-glomerular basement membrane (anti-GBM) antibodies. The underlying principle being tested here involves the specific target of these autoantibodies.

## **Why the Correct Answer is Right**
The correct answer, anti-glomerular basement membrane (anti-GBM) antibodies, is right because Goodpasture syndrome is specifically known for the production of these autoantibodies. These antibodies target the type IV collagen in the basement membranes of the glomeruli and alveoli, leading to the characteristic pulmonary hemorrhage and glomerulonephritis. The mechanism involves the direct binding of anti-GBM antibodies to the basement membrane, triggering an inflammatory response.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while basement membrane zones are involved in Goodpasture syndrome, the specificity is towards a particular component, not just any basement membrane zone in general.
- **Option B:** This option is incorrect because although immune complexes do play a role in various kidney diseases, Goodpasture syndrome is distinct in its involvement of anti-GBM antibodies rather than immune complex deposition.
- **Option C:** This option is incorrect because anti-neutrophil cytoplasmic antibodies (ANCA) are associated with different vasculitides, such as granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), but not specifically with Goodpasture syndrome.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that Goodpasture syndrome often presents with a combination of renal and pulmonary symptoms, such as rapidly progressive glomerulonephritis and pulmonary hemorrhage. Early diagnosis and treatment, typically involving plasmapheresis and immunosuppression, are critical to improve outcomes. Remember, the hallmark of Goodpasture syndrome is the presence of anti-GBM antibodies.

## **Correct Answer:** B. anti-glomerular basement membrane (anti-GBM) antibodies.